If the FDA says yes, a new weight loss medication may soon hit the shelves. Novo Nordisk has filed for FDA approval for a new high-dose formulation of its popular diabetes drug liraglutide to be...
The third time may not be the charm. Twice before the FDA has turned down the supplemental new drug application for an acute coronary syndrome indication for Johnson & Johnson’s Xarelto (...